GSK 923295 (CAS: 1088965-37-0)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51103-1ML | In Stock | 1mL(10mM in DMSO) | $298.50 | |
EBC51103-1MG | In Stock | 1mg | $58.50 | |
EBC51103-5MG | In Stock | 5mg | $148.50 | |
EBC51103-10MG | In Stock | 10mg | $268.50 | |
EBC51103-25MG | In Stock | 25mg | $553.50 |
Please Select The Country You Are In To Find Your Local Distributor. |
EbioCell | Phone:(540) 808-3925 | |
Imperial Business Park 4819 Emperor Boulevard, | E-mail:order@ebiocell.com | |
United States | Suite 408 Durham, NC 27703, USA | Web:www.ebiocell.com |
Product Information | |||||||||||||||||||||
Synonym(s) | GSK-923295 | ||||||||||||||||||||
Chemical Name | 3-chloro-N-[(2S)-1-[[2-(dimethylamino)acetyl]amino]-3-[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]propan-2-yl]-4-propan-2-yloxybenzamide | ||||||||||||||||||||
Application | GSK 923295 is a specific allosteric inhibitor of CENP-E kinesin motor ATPase | ||||||||||||||||||||
CAS Number | 1088965-37-0 | ||||||||||||||||||||
Purity | ≥99.0% | ||||||||||||||||||||
Molecular Weight | 592.13 | ||||||||||||||||||||
Molecular Formula | C₃₂H₃₈ClN₅O₄ | ||||||||||||||||||||
SMILES | C[C@@H](C1=CC=CN2C1=NC(=C2)C3=CC=C(C=C3)C[C@@H](CNC(=O)CN(C)C)NC(=O)C4=CC(=C(C=C4)OC(C)C)Cl)O | ||||||||||||||||||||
Target & IC50 | CENP-E | ||||||||||||||||||||
Solubility | DMSO: 100 mg/mL (168.88 mM)
Ethanol: 100 mg/mL (168.88 mM) |
||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20°C | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
GSK 923295 is a potent and selective mitotic kinesin Centromere protein E (CENP-E) inhibitor, a protein that accumulates in the G2 phase of the cell cycle. It is proposed to be one of the motors responsible for mammalian chromosome movement and spindle elongation. GSK923295 induces mitotic arrest and chromosome alignment failure. It is reported to be a potent inhibitor of tumor cell growth, which is further enhanced when MEK/ERK signaling is also inhibited. |
Specific Protocols | |